Endosaccular flow disruption with the Contour Neurovascular System: angiographic and clinical results in a single-center study of 60 unruptured intracranial aneurysms

摘要

The Contour Neurovascular System is a novel device designed to treat intracranial aneurysms by intrasaccular flow disruption. We report our experience and mid-term follow-up in a series of patients treated with the Contour.The patients were divided into an intention to treat and a per protocol population, the latter defined by the successful implantation of the Contour device. The intention to treat population included 53 patients (30 women, mean age 56 years) with 60 unruptured intracranial aneurysms (53 in the anterior circulation and seven in the posterior circulation). There was clinical and angiographic follow-up immediate postoperatively and at 24 hours, 3?months and 1?year using the Raymond–Roy classification and the O’Kelly–Marotta grading scale.The Contour was successfully implanted in 54/60 (90) aneurysms. With regard to the angiographic follow-up, there was adequate occlusion (defined as complete occlusion or presence of a neck remnant) in 31.5 of 54 aneurysms immediately postoperatively, 62.3 (in 53/54 aneurysms) at 24 hours, 81.4 (in 43/54 aneurysms) at 3?months, and 89.3 (in 28/54 aneurysms) at 1?year. Technical complications in 60 aneurysms of the intention to treat population included two (3.3) inadvertent detachments of the device. Thromboembolic events were observed in four of the 60 aneurysms (6.7), with no clinical symptoms in three patients and transient morbidity in one (1.7). No aneurysm bleeding was observed and no patient was retreated during the 1-year follow-up period. There was no permanent morbidity or mortality.The Contour device is effective and safe in the treatment of intracranial aneurysms. However, more experience and long-term follow-up are needed.